SEC Form 4 · accession 0001209191-16-133976
Dolby Laboratories, Inc. · DLB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin J Yeaman
Officer — President and CEO · Director
Period of report
Jul 25, 2016
Accepted (ET)
Jul 26, 2016 · 6:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001308547
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Jul 25, 2016 | M | 25,000 | $28.66 | A | 138,103 | I | By the Kevin and Rachel Yeaman Family Trust, dated May 14, 2009 |
| Class A Common StockF1 | Jul 25, 2016 | S | 25,000 | $50.0006 | D | 113,103 | I | By the Kevin and Rachel Yeaman Family Trust, dated May 14, 2009 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $28.66 | Jul 25, 2016 | M | 25,000 | D | — | Mar 16, 2019 | Class A Common Stock | 25,000 | 109,757 | I |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $50 to $50.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- F2This option was granted for a total of 134,757 shares of Class A Common Stock and became fully vested on March 16, 2013.
Remarks
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.